CS
ONCS

Credit Suisse’s OncoSec Medical Incorporated ONCS Stock Holding History

Credit Suisse’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-141
Closed -$17K – 4331
2019
Q1 		$17K Hold
141
– – ﹤0.01% 3947
2018
Q4 		$20K Buy
+141
New +$35.4K ﹤0.01% 3836

Other funds holding ONCS

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's ONCS Position: Q2 2019 in Review

Credit Suisse sold out of OncoSec Medical Incorporated (ONCS) in Q2 2019, closing a stake of 141 shares — an estimated $17K sold.

Credit Suisse first reported a position in ONCS in Q4 2018 and held it in 2 quarters. The position peaked at $20K in Q4 2018. 20 funds tracked by Wall St. Rank hold ONCS as of Q2 2019.

  • Credit Suisse reported no remaining OncoSec Medical Incorporated position as of Q2 2019 after selling out during the quarter.
  • Credit Suisse sold 141 OncoSec Medical Incorporated shares in Q2 2019, an estimated $17K.
  • Credit Suisse first reported a position in OncoSec Medical Incorporated in Q4 2018 and held it in 2 quarters.
  • Credit Suisse's OncoSec Medical Incorporated position peaked at $20K in Q4 2018.
  • 20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2019.

Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.